This application is a continuation of and claims priority to International Patent Application No. PCT/CN2018/077916, filed on Mar. 2, 2018, with the China Intellectual Property Office as the Receiving Office, which designated all contracting states bound by the Patent Cooperation Treaty on the international filing date. All claims of priority available are hereby made, and the entirety of the above identified application is hereby incorporated by reference.
The inventions described herein relate to polymers, hydrogels, and thermochromic agents, including products embodying them, methods of using them, and processes for making them. In certain embodiments, the inventions disclosed relate to temperature therapy packs which utilize thermochromic agents integrated into solid, semi-solid, or liquid hydrogels. In preferred (but optional) embodiments, the inventions described herein relate to thermochromic agents integrated into one or more compositions used as the temperature exchange material of a therapy pack. In certain other embodiments, the inventions described herein relate to methods of using the thermochromic integrated temperature exchange materials, or processes for manufacturing such thermochromic integrated temperature exchange materials and/or methods or processes for manufacturing or using thermal packs embodying such materials. In certain particularly preferred embodiments, one or more inventions described herein relate to novel polymer compositions and/or processes for making polymers, where product durability or longevity is improved and/or in which number of use cycles is improved or where usage times are increased.
The term of art “thermochromic”, as used throughout this specification, generally refers to pigments or dyes which, when exposed to changes in temperature, experience a change in color. Similarly, the term “reversible” when used to describe such pigments or dyes, reflects that the color changes obtained during thermal cycling may be reversed. Thermochromic pigments or dyes (or generally “thermochromic agents”) are known in a variety of arts ranging from the field of novelty items to the medical industry. Generally, thermochromic agents are used to either add or create aesthetic effects with no practical purpose other than entertainment, or are used as an indicator, of sorts, to identify temperature changes in items in which the thermochromic agents are embodied or otherwise utilized.
For example, U.S. Pat. No. 5,219,625 (“Matsunami”) discloses the use of thermochromic materials for application to clothing and toys for entertainment purposes. On the opposite end of the spectrum, International Publication No. WO 2016/093788 (“Isildak”) teaches the use of thermochromic agents to image blood vessels, such as to identify cancerous tumors which (according to the publication) include higher densities of blood vessels, for example. U.S. Publication No. 2009/0143516 (“MacDonald”) also teaches the use of thermochromic agents in the medical field, but in the implementation of such agents into gloves, so as to be able to determine whether a surgical glove is punctured. In still other uses of thermochromic agents, U.S. Publication No. 2014/0291585 (“Tozuka”) teaches to introduce thermochromic agents into the ink of writing instruments, so that if a mistake is made while writing, the writing ink (which includes thermochromic pigment) can be heated through friction to make the ink visually disappear.
In addition to the above uses, there is limited knowledge in the art of the use of thermochromic agents in the field of temperature therapy. For example, U.S. Publication No. 2013/0073018 (“Harwood”) teaches the use of thermochromic films applied to a thermal pack “cover” or “covering” for notifying the user as to when the pack is ready for use. However, the Harwood reference has many disadvantages which the applicants herein have addressed or solved with the present application for invention. For example, a thermal pack covering is not an accurate representation of the temperature of the therapy pack, nor is it a reliable indicator that the therapy pack is ready for therapeutic use. A thermal pack covering is exposed to ambient air and is also exposed to the skin of a pack user, or to a refrigerator surface, or table, or other surface, which the covering contacts when the thermal pack is chilled for use or placed on a surface prior to use. Therefore, the thermal pack coverings taught in Harwood are likely to change color at times responsive to (or at least impacted by) ambient air or skin (or other surface) temperatures, in contrast to providing an accurate measure of the temperature of the “core” of the temperature therapy pack itself. Consequently, the user of a pack, such as disclosed in Harwood, is likely to be misled by the color changing features disclosed therein. This is particularly true of the embodiments disclosed in Harwood in which a thermochromic agent is introduced into a fabric cover which is enshrouded over the disclosed temperature therapy packs to impart a particular aesthetic appearance (see, i.e., Harwood, para. [0029]).
The “temperature exchange material” of a thermal pack is the payload of the thermal pack which stores the hot or cold temperature (heat, or lack thereof in the case of a cold pack) for transfer to the skin or body part of an end user. Notably, Harwood nowhere teaches to integrate thermochromic agents into the temperature exchange material of a thermal pack itself. Moreover, Harwood nowhere teaches how to technically implement such an integration into the thermal exchange material of a thermal pack, or how to manufacture such a thermal pack. In particular, the applicants of the present invention have discovered that there are numerous difficulties and obstacles in doing so.
The applicants of the present invention have also discovered problems in the prior art pertaining to hydrogels, including the durability of hydrogels in semi-solid or solid form. Moreover, the applicants of the inventions disclosed herein have discovered that there are needs in the art for hydrogels, in solid, semi-solid, and/or fluid gel form, which durably integrate thermochromic agents. More generally, applicants have also discovered a need for polymers which integrate thermochromic agents which have improved lifespans (e.g., in storage and otherwise) and/or which have increased numbers of available use cycles and/or which exhibit improved usage times.
In view of the above-identified deficiencies in the art, the applicants for the inventions described herein have addressed, overcome, or solved such deficiencies (in whole or in part) with one or more of the below described methods, processes, or apparatus. It is, in certain embodiments, a purpose of the herein described methods, processes, or apparatus to address one or more of the above deficiencies or needs in the art. It is also a purpose of the herein described methods, processes, or apparatus to address other drawbacks and/or other desires for improvements in the art, whether or not currently known, which will become more apparent to the skilled artisan once given the present disclosure.
This invention, in some embodiments, relates to improvements in polymers, and/or to the use of thermochromic agents (e.g., such as thermochromic pigments or dyes) combined with or in conjunction with polymers. In other embodiments, this invention relates to therapy packs which deliver hot/cold temperature therapy to body parts of users. In preferred embodiments, hot/cold temperature therapy packs are provided which include or employ thermochromic agents. In certain other embodiments, the described inventions relate to hydrogels, including hydrogels in semi-solid, solid, and fluid form, which exhibit improved durability and/or which integrate or otherwise contain thermochromic agents. In certain preferred embodiments, these improved hydrogels, combined with thermochromic agents, are used as one or more temperature exchange materials of hot/cold temperature therapy packs.
In preferred embodiments, this application relates to novel thermochromic polymer or hydrogel compositions as well as processes for manufacturing such polymers or hydrogels to have useful thermochromic properties. In these embodiments, processes and methods for usefully and (preferably) durably integrating thermochromic agents into polymers and hydrogels are provided. In related embodiments, this application pertains to apparatus, such as temperature therapy packs, which are manufactured using the herein disclosed thermochromic compositions and/or using the herein described novel manufacturing methods and processes. Regardless of whether apparatus, method, or process, the applicants consider each and all of these embodiments (independently or combined) to be one or more aspects of their invention.
Although the applicants for this invention envision certain embodiments to be most preferred, any use of the term “preferred” is not intended to be limiting in any fashion. Moreover, the word “embodiment” should be broadly construed as reflecting an example of a genus or species of the inventions described herein. That is, regardless of whether described as “preferred” or as an “embodiment” (or as a “preferred embodiment”), the examples to which these terms refer are nevertheless optional, and variants therefrom are still considered by the applicants to be within the scope of their invention.
In one such example (i.e., optional) preferred embodiment, a temperature therapy pack is provided which utilizes hydrogel, formed into a plurality of beads (or microspheres) as a fill material to provide temperature exchange properties. In this embodiment, the hydrogel beads are installed into a preferably transparent therapy pack shell, such that the hydrogel beads are visually viewable by a user of the therapy pack. Moreover, in this preferred example, the hydrogel beads include or otherwise utilize one or more thermochromic agents (e.g., integrated into the beads), so that the beads will display useful color changing effects upon exposure to changes in temperature.
As an example utility for this preferred embodiment, temperature therapy packs filled (partially or fully) with hydrogel (in bead or fluid gel form) are constructed, utilizing a particularly selected thermochromic composition (or combination of thermochromic agents), so that the thermochromic agents provide one or more visual indicia to a user. Specifically, the thermochromic agents, or combinations thereof, are preferably selected to indicate that the therapy pack is sufficiently hot or cold for providing hot or cold temperature therapy to a user, respectively. Conversely, if the therapy pack is not hot or cold enough for temperature therapy, the pack is preferably designed to indicate this lack of readiness with a separate color, imparted by the thermochromic agents, or simply a lack of color (due to de-colorization of the thermochromic agent). For example, in applicants' most preferred embodiment, a temperature therapy pack is constructed of a transparent pack shell so that the thermochromic hydrogel beads contained in the pack gel are visible to a user. In this most preferred embodiment, the hydrogel beads appear blue when the therapy pack is not ready to provide temperature therapy (e.g., when they are at or near conventional room temperature). In contrast, when the hydrogel beads of the therapy pack appear as white or clear, the beads (acting as the thermal exchange material) have been sufficiently heated to provide heat therapy to a user. In certain preferred embodiments, the packs can be microwaved to heat them prior to use. However other methods of heating the packs may also be used, such as by placing the packs in hot water. Similarly, when the hydrogel beads of the therapy pack display the color purple, the beads have been sufficiently cooled (e.g., in a freezer, or in a cold water bath) to provide cold therapy to a user. Of course, other color combinations or schemes can be selected and used for providing temperature (or other status) indicia by selecting different thermochromic pigments or by otherwise tailoring the combination or composition of thermochromic agents used.
When the applicants for the herein disclosed inventions embarked on the process of creating the novel temperature therapy packs described herein, many unexpected obstacles and problems were encountered during the development process. For example, the thermochromic properties of the hydrogel beads which were impregnated with thermochromic agents had insufficient longevity (e.g. experienced color fading), and/or the hydrogel beads themselves exhibited poor structural durability. Such problems were exacerbated when the hydrogel beads were installed in prototype therapy packs which included lubricant (e.g., water) and/or antifreeze compositions so that the hydrogel beads would be permitted to move freely amongst other beads, and/or so that the lubricant would not freeze solid which cooled in a freezer. Other problems encountered pertained to the disbursement of thermochromic pigments within the hydrogels both evenly and in sufficient quantity to obtain product uniformity and/or sufficient thermochromic visual effect for adequately assisting with thermal therapy, respectively.
In order to solve these unforeseen problems, the applicants for the herein described inventions unpredictably discovered that reversible thermochromic properties could be obtained with sufficient longevity, and that improved hydrogel bead durability could be obtained, using novel manufacturing processes and/or compositions described herein. These novel compositions and processes include, but are not limited to, the novel hydrogel compositions disclosed herein, as well as methods and processes for manufacturing or processing the hydrogel beads. These compositions and/or processes allow a reversibly thermochromic temperature therapy pack to be manufactured which has a suitably long “shelf life” so that it can be successfully commercialized, without loss of significant product performance due to the passage of time when the product is shipped or is sitting on stores shelves prior to use. These uniquely made, novel temperature therapy packs are (optionally) also capable of changing color, through thermal cycling, in a greater number of use cycles. Moreover, the duration of color display is also improved.
Embodying the above or other improvements in the art, at least one embodiment of the herein disclosed inventions provides: a temperature therapy pack for providing hot and cold temperature therapy to a body part, and which displays color to indicate different therapy pack temperatures, comprising: a visually transparent temperature therapy pack enclosure; a first thermochromic agent having properties selected to display a first color X within a baseline temperature range T1 inclusive of room temperature, which de-colors above a temperature T2; a second thermochromic agent having properties selected to display a second color Y below a temperature T3 which is below the baseline temperature range T1, which de-colors above the temperature T3; a pack fill material being combined with the first and the second thermochromic agents to collectively comprise a reversible thermochromic, thermal exchange material, the reversible thermochromic, thermal exchange material being enclosed in the visually transparent temperature therapy pack enclosure; the temperature therapy pack being so configured such that when it is heated or cooled, the thermal exchange material retains heat or cold, respectively, so that the temperature therapy pack can be applied to a body part of a user to provide hot or cold temperature therapy; and wherein when the thermal exchange material of said temperature therapy pack is measurable at a temperature within the temperature range T1, the temperature therapy pack displays the first color X; when the thermal exchange material of the temperature therapy pack is measurable at a temperature above the temperature T2, the first and the second thermochromic agents each de-color; and when the thermal exchange material of the temperature therapy pack is measurable at a temperature below the temperature T3, the first color X and the second color Y, of the first and second thermochromic agents, respectively, each simultaneously display and thereby spectrally combine such that the temperature therapy pack displays a third color Z, which is a result of the spectral combination of colors X and Y.
In an alternative embodiment, there is provided: a temperature therapy pack for providing hot and cold temperature therapy to a body part, and which displays color to indicate different therapy pack temperatures, comprising: a visually transparent temperature therapy pack enclosure;
a first thermochromic agent having properties selected to display a first color X within a first temperature range, which de-colors outside of the first temperature range; a second thermochromic agent having properties selected to display a second color Y within a second temperature range, which de-colors outside of the second temperature range;
a pack fill material being combined with the first and the second thermochromic agents to collectively comprise a reversible thermochromic, thermal exchange material, the reversible thermochromic, thermal exchange material being enclosed in the visually transparent temperature therapy pack enclosure; the temperature therapy pack being so configured such that when it is heated or cooled, the thermal exchange material retains heat or cold, respectively, so that the temperature therapy pack can be applied to a body part of a user to provide hot or cold temperature therapy; and the first and the second thermochromic agents being particularly configured and selected such that when the thermal exchange material of the temperature therapy pack is measurable at a temperature within a temperature range T1, the temperature therapy pack displays a first color A; when the thermal exchange material of the temperature therapy pack is measurable at a temperature above the temperature range T1, the temperature therapy pack displays a second color B; and when the thermal exchange material of the temperature therapy pack is measurable at a temperature below the temperature range T1, the temperature therapy pack displays a third color C; and
wherein one of the first, second, or third colors A, B, or C respectively is a color obtained through the spectral combination of the other two colors, such that three temperature therapy pack display colors are obtained utilizing only two thermochromic agents.
In a particular preferred, yet still optional embodiment embodying the herein described improvements in the art, the reversible thermochromic materials developed by the applicants comprise the following compositions by mass fraction: polymer in the amount of 5%-40%; thermochromic powder in the amount of 1%-7%; dispersing agent in the amount of 1.5%-33%; dispersing auxiliary in the amount of 1.5%-35%; solvent in the amount of 5%-30%. Preferably, in this example, the polymer comprises at least one of the following components: polyacrylic acid polymer, natural polymer, and cellulose derivatives.
In at least one embodiment, the above-disclosed reversible thermochromic material (or composition) is used as part of a temperature therapy pack. In one such embodiment, for example, there is provided: a temperature therapy pack comprising: a temperature exchange material enclosed in a temperature therapy pack enclosure for providing temperature therapy to a user, the temperature exchange material being combined with a thermochromic agent, the combination of the temperature exchange material and the thermochromic agent comprising a reversible thermochromic, therapeutic material comprising, by mass fraction: polymer in the amount of 5%-40%; thermochromic powder in the amount of 1%-7%; dispersing agent in the amount of 1.5%-33%; dispersing auxiliary in the amount of 1.5%-35%; solvent in the amount of 5%-30%; and wherein the polymer comprises at least one of the following components: polyacrylic acid polymer, natural polymer, and cellulose derivatives.
In certain example embodiments which utilize the reversible thermochromic material described above, the polyacrylic acid polymer may optionally comprise at least one of the following components: polyacrylic acid, sodium polyacrylate, polyacrylamide, acrylamide/sodium acrylate copolymer, acrylamide/ethyl ammonium chloride acrylate copolymer, acrylamide/ethyl trimethyl ammonium chloride acrylate/ethyl ammonium chloride acrylate copolymer, acrylamide/sodium acrylate copolymer, acrylamide/sodium acryloyl dimethyl taurate copolymer, acrylic ester/acetoacetoxyethyl methacrylate copolymer, acrylic ester/beheneth-25 methacrylate copolymer, acrylic ester/beheneth-25 methacrylate/HEMA cross-linked polymer, acrylic ester/beheneth-25 methacrylate/HEMA cross-linked polymer-2, acrylic ester/C5-8 alkylacrylate copolymer, acrylic ester/C10-30 alkylacrylate cross-linked polymer, acrylic ester/C10-3 alkyl methacrylate copolymer, acrylic ester/ceteareth-20 methacrylate cross-linked polymer, acrylic ester/ceteareth-20 itaconate copolymer, acrylic ester/ceteareth-20 methacrylate polymer, acrylate cross-linked polymer-3, acrylate cross-linked polymer 4, acrylic ester/lauryl alcohol polyether-25 methacrylate copolymer, acrylic ester/lauryl alcohol polyether-25 acrylate copolymer, acrylic ester/lauryl alcohol polyether-25 itaconate, acrylic ester/stearyl alcohol polyether-50 acrylate copolymer, acrylic ester/stearyl alcohol polyether-20 itaconate copolymer, acrylic ester/stearyl alcohol polyether-20 methacrylate copolymer, acrylic ester/stearyl alcohol polyether-30 methacrylate copolymer, acrylic ester/stearyl methacrylate copolymer, acrylic ester/vinyl isodecanoate cross-linked polymer, acrylic ester/vinyl neodecanoate cross-linked polymer, acrylic acid/acrylonitrile copolymer, acrylic acid/phosphorylcholine glycol acrylate cross-linked polymer, ammonium acrylic ester/acrylonitrile copolymer, ammonium acrylate copolymer, ammonium acryloyldimethyltaurate/carboxylic ethyl acrylate cross-linked polymer, ammonium acryloyldimethyltaurate/stearyl alcohol polyether-8 methacrylate copolymer, C18-22 alkyl PEG-25 methacrylate/2-Diethylaminoethyl methacrylate copolymer, glyceryl acrylate/acrylic acid copolymer, HEA/sodium acryloyldimethyltaurate/stearyl alcohol polyether-20 methacrylate copolymer, potassium polyacrylate, sodium acrylate/acrylaldehyde copolymer, sodium acrylate/acrylonitrile copolymer, sodium acrylate/acryloyldimethyltaurate/dimethylacrylamide cross-linked polymer, sodium acrylate/beheneth-25 methacrylate cross-linked polymer, sodium acrylate copolymer, sodium acrylate/sodium acrylamide methylpropane sulfonate copolymer, sodium acrylate/sodium acryloyldimethyltaurate/acrylamide copolymer, sodium acrylate/sodium acryloyldimethyltaurate copolymer, sodium acrylate/vinyl isodecanoate cross-linked polymer, sodium acrylate/vinylacetamide copolymer, sodium acrylate/vinyl alcohol copolymer, sodium acryloyldimethyltaurate/acrylamide/VP copolymer, sodium styrol/acrylate copolymer, sodium polymethacrylate, sodium polyacrylate starch, sodium taurate acrylate/acrylic acid/acrylonitrile copolymer, starch/acrylate/acrylamide copolymer, and tromethamine acrylate/acrylonitrile copolymer.
Although not in all embodiments, in certain preferred embodiments, the polyacrylic acid polymer described above is (preferably) generated from the reaction of monomers with initiators. In at least one of such embodiments, the monomers include acrylic acid and the relevant acrylate, acrylamide and acrylic ester, and the initiators include potassium persulfate, ammonium persulfate, tert butyl hydroperoxide and dimethyl sulfonyl peroxide. In particularly preferred (but still optional) embodiments, the mass ratio of the monomer and initiator ranges from 50:1-200:1. As a further beneficial but optional preference, the raw materials for the polymerization of polyacrylic polymer also include a crosslinking agent, which includes N,N′-methylene bisacrylamide. Moreover, the preferred mass ratio of the crosslinking agent to monomer is approximately 1:100-1:200.
In preferred, but still optional embodiments of the reversible thermochromic aspects of the inventions described herein, it has been found useful to use natural polymers comprising at least one of the following components: agar, ammonium alginate, algin, alginic acid, amylopectin, gum tragacanth, calcium alginate, carrageenen, cassia gum, locust bean gum, quinoa starch, Guar bean gum, dehydroxanthan gum, alsace gum, carrageenin, gelatine, Gellan gum, Ghatti gum, magnesium alginate, Natto gum, pectine, potassium alginate, potassium carrageenan, peach gum, Rhizobian gum, Sclerotium gum, sodium carraghenate, gum sterculia, Tamarindus Indica seed gum, tapioca, TEA-alginate, Welan gum, and Xathan gum. In the most preferable embodiments, the natural polymer is at least one polymer selected from the group comprising: agar, ammonium alginate, carrageenan, gelatin, Gellan gum and Xathan gum. Such natural polymers have a long-chain macromolecule structure and excellent thickening and gelling effects. Used in the novel processes and compositions described herein, they wrap the thermochromic powder effectively, with no destructive effect on the thermochromic powder, thereby obtaining stronger structure and longer thermochromic life.
In combination with the optional embodiments described above, or in other embodiments described elsewhere herein, the cellulose derivatives utilized in the reversible thermochromic materials may optionally comprise: oxyhydroxypropyl cetyl hydroxyethylcellulose, calcium carboxymethylcellulose, C12-16 alkyl PEG-2 hydroxypropyl hydroxyethyl ethylcellulose, carboxymethyl cellulose acetate butyrate, carboxymethyl hydroxyethyl cellulose, cellulolytic enzyme, cellulose acetate propionate, calcium octenyl succinate starch, glyceryl alginate, hydrolyzed cellulose gum, hydroxyethyl chitosan, hydroxypropyl chitosan, hydroxypropyl guar gum, hydroxypropyl starch, hydroxypropyl starch phosphate, hydroxypropyl xanthan gum, ethyloic chitin, carboxymehyl chitosan, sodium carboxymethyl chitin, sodium carboxymethyl dextrin, sodium polygluconate, carboxymethyl starch sodium, carboxymethyl glucosan, sodium starch octenyl succinate, starch hydroxypropyl trimethyl ammonium chloride, hexadecyl hydroxyethyl cellulose, croscarmellose, carboxymethyl hydroxypropyl guar gum, ethyl cellulose, sodium carboxymethyl cellulose, hydrogenated bovine base benzyl dimethyl bentonite, hydroxybutyl methyl cellulose, hydroxyethyl cellulose, hydroxy propyl cellulose, hydroxypropyl methylcellulose, methyl cellulose, methyl ethyl cellulose, methyl hydroxyethyl cellulose, microcrystalline cellulose, nonylphenol polyether hydroxyethyl cellulose, oxycellulose, sodium cellulose sulfate, and/or stearoxy PG-hydroxyethylcellulose sulfonate. Most preferably, the cellulose derivative is one or more of the materials selected from the group comprising: calcium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methylcellulose. Used in the compositions and processes described herein, such cellulose derivatives have excellent thickening effect. Like the natural polymers specified supra for applicant's compositions and processes, they also wrap the thermochromic powder effectively, with no destructive effect on the thermochromic powder. This results in a stronger structure and longer thermochromic life.
In certain embodiments, the reversible thermochromic materials described herein (preferably) use a dispersing agent comprising Tween-20, -40, -60, -80 and -85 and Span-40, -60 and -80. In such or other preferred embodiments, the dispersing auxiliary may optionally comprise allyl alcohol, n-propanol, butanetriol, polyethylene glycol and/or polyglycerol. In the most preferred embodiments, the dispersing auxiliary is allyl alcohol, n-propanol or butanetriol. Use of these most preferred dispersing auxiliaries unexpectedly obtains better dispersing performance, resulting in more uniform color and longer life.
In some embodiments of the invention, it has been found useful to utilize thermochromic agents in the form of thermochromic powder. In example embodiments using such thermochromic powder, the identity of the powder may be selected so that the material either develops or changes color when heated or cooled (thermal color-developing type) or loses color when heated or cooled (thermal de-coloring type). In still other embodiments, blends of powders or other thermochromic agents may be used to obtain a plurality of thermochromic or color changing effects, all in the same product. Preferably, the chromogenic temperature section of the thermochromic powder is in any temperature range of −20° C. to 80° C. The thermochromic powder is distinguished by using the temperature color change thresholds to characterize the powder.
The method for preparing the reversible thermochromic material disclosed herein includes the following process steps: uniformly mixing the polymers, dispersing agent, dispersing auxiliary, thermochromic powder, and solvent. In a particularly efficacious example, applicant determined that the premixing the thermochromic powder, in the following process, produces particularly desirable compositions and functional results: premix the thermochromic powder with dispersant, solvent and dispersing auxiliary to obtain a thermochromic color paste. Then, mix the thermochromic color paste with polymer to obtain a gel composition. Using this preparation step, described in more detail in the DETAILED DESCRIPTION section of the specification, uniform dispersion of the thermochromic agent within the gel composition is more readily obtained.
In an alternative embodiment, the thermochromic gel composition may be prepared as follows: mixing the dispersing agent, dispersing auxiliary, solvent and thermochromic powder. The resulting mixture is then added to the solution containing monomers and initiators and used for preparing said polymers to gain mixed liquid. The liquid is then added drop by drop into the oil to allow the polyreaction. Afterwards, upon completion of the polyreaction, the products generated are cleaned and dried to form the thermochromic material.
In certain preferred embodiments, the solvent utilized to manufacture the reversible thermochromic material may comprise at least one of the following components: water, glycerin, ethanol and propylene glycol.
When developing the herein described products and processes, the applicants for the herein disclosed inventions discovered that pigment particle size was a significant factor in obtaining suitable product performance and durability. More specifically, applicants have unexpectedly discovered that if the particle size is too large, particles do not effectively disperse in the polymers and gels described herein, which can lead to gel structural failure (e.g., particularly where the polymers are formed into semi-solid forms, such as beads). Further, if the particle size is too small, the displayed color is faint and/or the thermochromic life is short due to the small amount of coated thermochromic material. Moreover, using thermochromic powder of small particle size entails more stringent process preparation parameters, and lower yield is obtained. In addition, it has been discovered that the use of too small particle sizes is an obstacle to obtaining sufficiently long storage life in the final product. Consequently, applicants have discovered a heretofore unknown useful range of beneficial thermochromic pigment particle sizes, generally between 5-20 micrometers, which unexpectedly provide the advantages described elsewhere herein. Thus, thermochromic powders with a grain (or particle) size between 5-20 micrometers are most preferably used. But, grain size may also be between approximately 3-25 micrometers or between approximately 1-30 micrometers.
Thermochromic colorants may be made of from a wide range of molecules including, for example, spiropyrans, spirooxazines, lactones, spirolactones, diazarhodamine lactones, fulgides, chromenes, azobenzenes, quinones, styrylquinolines, fluorans, bianthrones, polythiophenes, polysilanes, polydiacetylenes, phenolphthaleins, merocyanines, anils, diphenylmethane phthalides, phenylindolylphthalides, indolylphthalides, diphenylmethane azaphthalides, phenylindoly-lazaphthalides, dihydroazulenes, vinylheptafulvenes, quinazolines, bisquinazolines, trisubstituted pyridines, liquid crystals, and combinations thereof. More specific examples may include 6-nitro-1′,3′,3′-trimethylspiro-[2H-1-benzopuran-2,2′-indoline]; (E)-2-[1-(2,5-dimethyl-3-furyl)]ethylidene-(Z)-3-ethylidene-succinic anhydride; 1,2-dicyano-1,2-bis-(2,4,5-trimethyl-3-thienyl)ethane; 2,3-bis(2,4,5-trimethyl-3-thienyl)maleic anhydride; 3,3-bis(pdimethylaminophenyl)-6-dimethylaminophthalide; 3-(4-diethylaminophenyl)-3-(1-ethyl-2-methylindol-3-yl) phthalide; 3,3-bis(1-n-buty-1-2-methylindol-3-yl)phthalide; 3,3-bis(2-ethoxy-4-diethylaminophenyl)-4-azaphthalide; 3-[2-ethoxy-4-(N-ethylanilino)phenyl]-3-(1-ethyl-2-methylindol-3-yl)-4-azaphthalide; 3,6-dimethoxyfluoran; 3,6-di-n-butoxyfluoran; 2-methy-1-6-(N-ethyl-N-ptolylamino) fluoran; 3-chloro-6-cyclohexylaminofluoran; 2-methyl-6-cyclohexylaminofluoran; 2-(2-chloroanilino)-6-di-n-butylaminofluoran; 2-(3-trifluoromethylanilino)-6-diethylaminofluoran; 2-(N-methylanilino)-6-(N-ethyl-Np-tolylamino) fluoran, 1,3-dimethyl-6-diethylaminofluoran; 2-chloro-3-methyl-6-diethylaminofluoran; 2-anilino-3-methyl-6-diethylaminofluoran; 2-anilino-3-methyl-6-di-n-butylaminofluoran; 2-xylidino-3-methyl-6-diethylaminofluoran; 1,2-benzo-6-diethylaminofluoran; 1,2-benzo-6-(N-ethyl-N-isobutylamino)fluoran; 1,2-benzo-6-(N-ethyl-N-isoamy-lamino)fluoran; 2-(3-methoxy-4-dodecoxystyryl)quinoline; spiro[5H-(1)benzopyrano(2,3-d)pyrimidine-5,1′(3′H)isobenzofuran]-3′-one; 2-(diethylamino)-8-(diethylamino)-4-methylspiro[5H-(1)benzopyrano(2,3-d)pyrimidine-5,1′(3′H)isobenzofuran]-3′-one; 2-(di-nbutylamino)-8-(di-n-butylamino)-4-methyl-spiro[5H-(1)benzopyrano(2,3-d)pyrimidine-5,1′(3′H)isobenzofuran]-3′-one; 2-(di-n-butylamino)-8-(diethylamino)-4-methyl-spiro[5H-(1)benzopyrano(2,3-d)pyrimidine-5,1|(3|H)isobenzofuran]-3′-one; 2-(di-n-butylamino)-8(N-ethyl-N-isoamylamino)-4-methyl-spiro[5H-(1)benzopyrano(2,3-d)pyrimidine-5,1′(3′H)isobenzofuran]-3′-one; 2-(di-nbutylamino)-8-(di-n-butylamino)-4-phenyl, and combinations thereof.
In addition to organic molecules, inorganic compounds can also produce thermochromic responses such as: Ag2Hg2I4, Cu2HgI4, and SrCO3 and MnO2 composite resins. In certain cases, the use of solutions of inorganic compounds such as CoCl2 can be used to synthesize thermochromic materials in the presence of unsaturated esters, peroxides, and an accelerator.
In accordance with the above teachings, at least one optional method for obtaining the advantages described herein (or other advantages not yet contemplated) is provided as a method of manufacturing a thermal pack comprising: i) providing the following materials in amounts, determined by mass fraction, comprising: polymer in an amount of approximately 5%-40%; thermochromic powder in an amount of approximately 1%-7%; dispersing agent in an amount of approximately 1.5%-33%; dispersing auxiliary in an amount of approximately 1.5%-35%; solvent in an amount of approximately 5%-30%; and ii) preparing a thermal exchange material by performing the following steps: mixing the dispersing agent, the dispersing auxiliary, the solvent, and the thermochromic powder, to obtain a thermochromic composition; mixing the thermochromic composition with a polymer pre-cursor material, to obtain a mixed liquid; maintaining a pH of the mixed liquid between approximately 3-10; initiating polymerization of the mixed liquid at a temperature selected between approximately 40-88° C., to obtain a reversible thermochromic polymeric thermal exchange gel material; iii) installing the reversible thermochromic polymeric thermal exchange gel material into a visually transparent temperature therapy pack enclosure.
As an additional optional feature of the embodiments described herein, applicants discovered that ultraviolet light negatively impacted product durability and performance. Therefore, in some preferred (but still optional) embodiments, ultraviolet coatings or filtering layers are utilized, such as applied on the transparent thermal pack shell (or elsewhere).
Certain examples of the invention are now described below, with respect to certain non-limiting embodiments thereof, as illustrated in the following drawings wherein:
The drawings submitted herewith, which form a part of this patent application, each illustrate an embodiment, or one or more components of an embodiment, of a non-limiting example of applicants' invention. While these drawings depict certain preferred embodiments of applicants' invention, as well as certain particularly desirable features thereof, they are intended to be examples only and should not be construed to limit the scope of applicants' invention.
For a more complete understanding of the present invention, reference is now made to the following description of various illustrative and non-limiting embodiments thereof, taken in conjunction with the accompanying drawings in which like reference numbers indicate like features. These example embodiments, disclosed and discussed below, will assist in a further understanding of the inventions described and claimed herein, but they are not intended to limit the scope of the invention in any way.
Referring initially to
By joining only the edges or perimeter of the sheets, the sealed edge 9 is obtained while leaving the interior of the shell or pouch with a defined volume which is filled with the plurality of spherical elements 5, as illustrated. As described in further detail in conjunction with the examples provided below, spherical elements 5 are preferably semi-solid gel beads, formed from a polymeric hydrogel impregnated with thermochromic agents 7 (See
As will be readily appreciated, because thermochromic hydrogel beads are utilized (in this embodiment), pack 1 is preferably constructed using a pack shell which is transparent, or which at least includes portions which are transparent, so that the color-changing properties of the beads within pack 1 can be viewed by the pack user. Thus, for example, the entire pack shell may be transparent or, alternatively, one side may be transparent with the other side being formed of an opaque fabric for comfort. Further alternatively, transparent windows may be provided in an otherwise opaque pack shell so that the thermochromic beads may be viewed by a user.
As discussed above, the preferred embodiments of the herein described inventions utilize thermochromic pigments incorporated into temperature therapy packs, so that the (approximate) temperature of the therapy pack can be readily ascertained by simply viewing the color of the pack itself. By incorporating thermochromic properties as such, by simply viewing the color of the therapy pack, it is possible to readily determine whether the pack is heated or cooled, and thus ready to provide temperature therapy. Moreover, it is possible to ascertain, simply by viewing the pack, which type of therapy the pack is ready to deliver. Nevertheless, it is always recommended to measure the temperature of the heated or cooled therapy pack prior to use (to verify that it is not too hot or too cold), to prevent burns or frost bite.
For heat treatments to be therapeutic, the temperature of the hot/cold pack should be at least several degrees Celsius above the skin temperature of a user. Similarly, for cold treatments to be therapeutic, the temperature of the hot/cold pack should be at least several degrees Celsius below the skin temperature of the user. Thus, for effective cold therapy, the temperature exchange material of a therapy pack (e.g., elements 5 of pack 1) should be cooled to a suitably cool temperature, such as by cooling the pack in a freezer (or using a cold water bath, or other suitable method). Conversely, for effective hot therapy, the temperature exchange material of a therapy pack should be heated to a suitably warm temperature, which may be accomplished by microwaving the pack (or using hot water, or other suitable method). Too high or too low temperatures should always be avoided for safety reasons. Therefore, the temperature of the pack should always be tested before use.
Recognizing that certain temperature ranges are desirable, preferred embodiments of the thermal packs described herein are configured so that color indicia are displayed when the temperature exchange material falls within such temperature ranges, and also so that separate color indicia is displayed when the temperature exchange material falls outside of those ranges. For example, in one particularly preferred embodiment, a pack is configured to include a temperature exchange material composition, which includes specifically selected thermochromic agents so that the exemplar thermal pack appears blue when at room (non-therapeutic) temperature, purple when it is cooled to the temperature range suitable for doctor recommended cold therapy, and white or clear when it is heated to the temperature range suitable for doctor recommended heat therapy. Of course, any temperature ranges described herein are not intended to be limiting, and the thermal packs described herein can be tailored to display such colors in different temperature ranges (or, in another example, to display different colors within the same ranges).
Generally speaking, thermochromic colorants function by selectively absorbing a portion of the visible spectrum of light, leaving the remaining portion of the spectrum to be reflected and thus observed. Thus, when thermochromic colorants are integrated into a thermal exchange material, such as a solid, semi-solid, or continuous gel, the apparent color of the gel, at a given temperature, will depend on the colors reflected (i.e., not absorbed) at the respective temperature. On this same point, it is important to note that thermochromic materials can be designed (or selected) so that they display color above or below threshold temperatures (i.e., develop or turn on), or de-color above or below threshold temperatures (i.e., turn off). For example, a red de-coloring thermochromic powder may display the color red at temperatures below 0° C., but display no color (i.e., be colorless) at temperatures above 0° C. Conversely, a red developing thermochromic powder may display no color (i.e., appear colorless) at temperatures below 50° C., but display the color red at temperatures above 50° C.
As one facet of the many improvements to the prior art described herein, applicants have discovered a composition and process to obtain a thermal pack product which visually indicates three temperature ranges, using only two thermochromic agents, thereby saving the costs of the use of a third thermochromic agent, while also obtaining a thermal exchange material, in gel form, which is more stable, and which exhibits improved reversible thermochromic performance. As one example of such an improved thermal exchange gel, the gel is formed from a particularly selected composition so that the gel appears blue at room temperature (between approximately 0 and 38 degrees Celsius), colorless/white above 38 degrees Celsius (e.g., at temperatures effective for heat therapy), and purple below 0 degrees Celsius (e.g., at temperatures effective for cold therapy). Such a product, as described in more full detail infra, utilizes the two thermochromic agents synergistically to create a third color, by reflecting two colors simultaneously (within a pre-selected temperature range), so that the spectrum of the two colors reflected blends visually thereby appearing as a third color. In this specific embodiment, for example, the thermochromic pigments are selected so that the first—in this case blue—thermochromic agent de-colors (absorbing all wavelengths to appear clear or white) above 38 degrees Celsius, while otherwise appearing blue at any temperature below 38 degrees Celsius. The second thermochromic agent—in this case red—normally appears white or clear at any temperature above 0 degrees Celsius but develops into the color red below such temperature. Consequently, in a temperature range where the blue thermochromic pigment has not de-colored (and therefore displays as blue) and the red thermochromic pigment has developed to display red—in this case the temperature range below 0 degrees Celsius—the reflected blue and red light spectrums combine and visually appear purple to a human eye.
As aforesaid, in the example embodiment illustrated, the exemplary product described displays three colors—white/colorless, blue, and purple—in three different temperature ranges, but using only two thermochromic pigments. The elimination, in this instance, of the use of a third thermochromic pigment (to obtain the third color) not only saves costs (i.e., thermochromic pigments are expensive) but also results in a more structurally stable, better performing color product, particularly when the utilized thermochromic pigments are blended as a powder with a grain size selected between approximately 5-20 micrometers. In such instance, the grain particle size contributes to this better performance, as does the use of less thermochromic pigment (the smaller amount of pigment thereby replacing less polymer, resulting in a stronger gel product).
In the embodiment described immediately above, the two thermochromic powders are blended with a polymer mixture which is further processed to form either a continuous gel or a plurality of semi-solid (or solid) hydrogel beads. In the example embodiment employing beads, the resulting gel bead product is then installed in a (preferably) transparent thermal pack shell, as the plurality of spherical elements 5, and thereafter serves the role of the temperature exchange material of the thermal pack depicted in
Pack 1, as illustrated in
General Procedure:
Generally speaking, one method of preparing the thermochromic polymers, useful as thermal exchange materials, is performed using the following steps:
Step 1: Mix the dispersant, dispersing auxiliary, solvent, and thermochromic powder. Combine the pre-mixed thermochromic composition with the raw polymerization material obtained from the polyacrylic polymer (and/or cellulose derivative) to obtain a mixed liquid. Preferably maintain the pH of the mixed liquid between approximately 3-10.
Step 2: Initiate polymerization of the mixed liquid at 40-88° C., to obtain thermochromic hydrogel (to be used in continuous gel or microsphere form). Avoid high reaction temperatures which will damage or destroy the thermochromic powder (or its properties) or lead to colloidal implosion. Avoid too low reaction temperatures which will result in failure of polymerization.
In Step 2, if microspheres are being prepared, drip the mixed liquid during polymerization into an oil solution (e.g., silicone oil) in which beads will form. Afterwards, clean the microspheres (or beads) to remove the oil. The cleaning time is preferably approximately 10-30 minutes, and the cleaning temperature is preferably approximately 0-45° C. Afterwards, dry the microspheres at low temperature, preferably between 40-80° C., for approximately 1-4 hours. Applicant has discovered that it is necessary to avoid higher drying temperature ranges, because such higher drying temperatures damage the thermochromic pigments resulting in shorter pigment life and fewer available color change cycles. Conversely, applicant has discovered that drying with lower temperatures reduces process efficiency.
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps: premixing the thermochromic powder with dispersant, solvent and dispersing auxiliary to obtain thermochromic color paste, and mixing the thermochromic color paste with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 1.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (using steps described elsewhere in the specification). The thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps: premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste. The thermochromic color paste is thereafter mixed with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 2.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (using steps described elsewhere in the specification). The thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps: premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste. The thermochromic color paste is thereafter mixed with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 3.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (or beads). Afterwards, the thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a plurality of reversible thermochromic microspheres, comprising the following steps:
Mixing the dispersant, dispersing auxiliary, solvent, and thermochromic powder, and thereafter adding such mixture to the polymerization raw material of the polyacrylic polymer (or mixed solution of monomer and initiator) to obtain a mixed liquid. Afterwards, the mixed liquid is dripped into an oil phase, to allow the polymerization reaction to form thermochromic microspheres. The polymerization temperature is preferably controlled to remain between 40° C.-88° C. Higher or lower temperatures can prevent formation of the microspheres. After completion of polymerization, clean the microspheres (or beads) to remove the oil. The cleaning time is preferably approximately 10-30 minutes, and the cleaning temperature is preferably approximately 0-45° C. Afterwards, dry the microspheres at low temperature, preferably between 40-80° C., for approximately 1-4 hours. Applicant has discovered that it is necessary to avoid higher drying temperature ranges, because such higher drying temperatures damage the thermochromic pigments resulting in shorter pigment life and fewer available color change cycles. Conversely, applicant has discovered that drying with lower temperatures reduces process efficiency. After cleaning and drying is complete, the plurality of microspheres obtained are useful as a thermal exchange material.
The specific components and their contents in the embodiment are as shown in Table 4.
After the gel-form, microsphere-configured thermal exchange materials are obtained, the thermal exchange material is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps:
Mixing the dispersant, dispersing auxiliary, solvent, and thermochromic powder, and thereafter adding such mixture to the polymerization raw material of the polyacrylic polymer (or mixed solution of monomer and initiator) to obtain a mixed liquid. Afterwards, the mixed liquid is directly polymerized between approximately 40-88° C. to obtain a continuous gel form thermal exchange material.
The specific components and their contents in the embodiment are as shown in Table 5.
The gel-form thermal exchange material prepared in the embodiment is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps:
Premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste, and thereafter mixing the thermochromic color paste with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 6
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (or beads). Afterwards, the thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps:
Premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste, and thereafter mixing the thermochromic color paste with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 7.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (or beads). Afterwards, the thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps:
Premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste, and thereafter mixing the thermochromic color paste with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 8.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (or beads). Afterwards, the thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
This embodiment relates to a method for preparing a reversible thermochromic gel, comprising the following steps:
Premixing the thermochromic powder with dispersant, solvent, and dispersing auxiliary to obtain thermochromic color paste, and thereafter mixing the thermochromic color paste with polymer to obtain a gel-form thermal exchange material. The specific components and their contents are as shown in Table 9.
The gel-form thermal exchange material prepared in the embodiment may be used in continuous gel form, or alternatively formed into gel microspheres (or beads). Afterwards, the thermal exchange gel is preferably installed into a thermal pack shell, such as the exemplar shell depicted as 3 in
The embodiment relates to a method for preparing a reversible thermochromic gel; the preparation steps are basically the same as that in Embodiment 1, except that: the content of sodium polyacrylate is 45% and the content of allyl alcohol is 30%.
The embodiment relates to a method for preparing a reversible thermochromic gel; the preparation steps are basically the same as that in Embodiment 1, except that: the content of thermochromic powder is 0.5% and the content of allyl alcohol is 34.5%.
The embodiment relates to a method for preparing a reversible thermochromic gel; the preparation steps are basically the same as that in Embodiment 1, except that: the dispersing auxiliary is ethylene glycol.
The embodiment relates to a method for preparing a reversible thermochromic gel; the preparation steps are basically the same as that in Embodiment 1, except that: the solvent is methanol.
The embodiment relates to a method for preparing a reversible thermochromic gel; the preparation steps are basically the same as that in Embodiment 1, except that: the particle size of thermochromic powder is 25 microns.
The embodiment relates to a method for preparing a reversible thermochromic microsphere; the preparation steps are basically the same as that in Embodiment 3, except that: the polymerization temperature is controlled at 100° C.
The embodiment relates to a method for preparing a reversible thermochromic microsphere; the preparation steps are basically the same as that in Embodiment 3, except that: the cleaning temperature of the thermochromic microsphere is controlled at 50° C.
Performance Test
The 50° C. accelerated aging test method was used to test the storage life, and to simulate the actual use conditions, in order to approximate the times for which the color change performance of the product will be available. That is, in addition to testing the product for a sufficiently long shelf-life prior to use, the tests performed were designed to determine when or whether the thermochromic pigments will lose performance, upon being subjected to hot and cold thermal cycling (e.g., heating and freezing). The tests were performed for the thermochromic product prepared in each embodiment described above. The test results are as shown in Table 10 below:
Although the above disclosed thermal pack embodiments have generally been discussed in connection with
In optional embodiments of the thermal packs enabled by this specification, the thermal packs may be configured and shaped to conform to specific human body parts. For example,
In certain example embodiments, the percentage of hydrogel beads withing the pack volume may range from 10% to 100%, including between 20% to 80% and between 40% to 60% with the balance of the volume, if any, comprising liquid and/or air. Morever, the hydrogel beads may all be solid, or they may be a combination of solid and hollow beads to enable tailoring of thermal exchange properties.
In addition to the advantages already described above, the following additional advantages of the herein described inventions are obtained alone, or in combination, with one or more of the above-described embodiments:
Once given the above disclosure, many other features, modifications, and improvements will become apparent to the skilled artisan. Such features, modifications, and improvements are therefore considered to be part of this invention, without limitation imposed by the example embodiments described herein. Moreover, any word, term, phrase, feature, example, embodiment, or part or combination thereof, as used to describe or exemplify embodiments herein, unless unequivocally set forth as expressly uniquely defined or otherwise unequivocally set forth as limiting, is not intended to impart a narrowing scope to the invention in contravention of the ordinary meaning of the claim terms by which the scope of the patent property rights shall otherwise be determined:
Number | Date | Country | Kind |
---|---|---|---|
PCT/CN2018/077916 | Mar 2018 | WO | international |
Number | Name | Date | Kind |
---|---|---|---|
264814 | Wood | Sep 1882 | A |
D45122 | Meincke | Jan 1914 | S |
1690405 | Du Rocher | Nov 1928 | A |
1924315 | Hemphill et al. | Aug 1933 | A |
2038275 | Fogg | Apr 1936 | A |
D111793 | Myers | Oct 1938 | S |
D164087 | Atkin | Jul 1951 | S |
2932052 | Morse | Apr 1960 | A |
2955331 | Nelson | Oct 1960 | A |
D204884 | Waddington | May 1966 | S |
3301254 | Schickendanz | Jan 1967 | A |
3382511 | Brooks | May 1968 | A |
3545230 | Morse | Dec 1970 | A |
D223701 | Lausch | May 1972 | S |
3736769 | Petersen | Jun 1973 | A |
3768485 | Linick | Oct 1973 | A |
3804077 | Williams | Apr 1974 | A |
D232995 | Molzen | Oct 1974 | S |
3885403 | Spencer | May 1975 | A |
D242958 | Manschot et al. | Jan 1977 | S |
D243121 | Ralston et al. | Jan 1977 | S |
D243715 | Trimnell | Mar 1977 | S |
D245119 | Harris | Jul 1977 | S |
4122847 | Craig | Oct 1978 | A |
D251258 | Power | Mar 1979 | S |
D251576 | Geenen-Meegens | Apr 1979 | S |
D258532 | Wagner | Mar 1981 | S |
4316287 | Rule | Feb 1982 | A |
D265704 | Yamamoto | Aug 1982 | S |
4462224 | Dunshee et al. | Jul 1984 | A |
4470417 | Gruber | Sep 1984 | A |
D278363 | Schenkel et al. | Apr 1985 | S |
4530220 | Nambu et al. | Jul 1985 | A |
4559047 | Kapralis et al. | Dec 1985 | A |
4585797 | Cioca | Apr 1986 | A |
4614189 | MacKenzie | Sep 1986 | A |
4645498 | Kosak | Feb 1987 | A |
4668564 | Orchard | May 1987 | A |
D293004 | Emms | Dec 1987 | S |
D293829 | Johnston | Jan 1988 | S |
4727869 | Leonardi | Mar 1988 | A |
D296838 | Diaz | Jul 1988 | S |
D296930 | Carabelli | Jul 1988 | S |
D300645 | Bowden | Apr 1989 | S |
D301280 | Craig et al. | May 1989 | S |
D302213 | Motazedi | Jul 1989 | S |
4917112 | Kalt | Apr 1990 | A |
D308787 | Youngblood | Jun 1990 | S |
D312558 | Ilsen et al. | Dec 1990 | S |
D318075 | Capper et al. | Jul 1991 | S |
5050595 | Krafft | Sep 1991 | A |
D320457 | Dickinson | Oct 1991 | S |
D324915 | Wastchak | Mar 1992 | S |
D325089 | Shaw | Mar 1992 | S |
D326222 | McAtarian | May 1992 | S |
D327329 | Hubbard et al. | Jun 1992 | S |
D327330 | Noble | Jun 1992 | S |
5129391 | Brodsky et al. | Jul 1992 | A |
D328792 | Salmon et al. | Aug 1992 | S |
D329497 | Pryor | Sep 1992 | S |
D330427 | Meijer | Oct 1992 | S |
5163425 | Nambu | Nov 1992 | A |
D332310 | Ahlen | Jan 1993 | S |
5179944 | Mcsymytz | Jan 1993 | A |
5190033 | Johnson | Mar 1993 | A |
D336339 | Pryor | Jun 1993 | S |
5219625 | Matsunami et al. | Jun 1993 | A |
D341022 | Zona | Nov 1993 | S |
D341284 | Martin | Nov 1993 | S |
5274865 | Takehashi | Jan 1994 | A |
D343903 | Perteet | Feb 1994 | S |
5300103 | Stempel et al. | Apr 1994 | A |
5300105 | Owens | Apr 1994 | A |
5304215 | MacWhinnie | Apr 1994 | A |
5314005 | Dobry | May 1994 | A |
D348174 | Genis | Jun 1994 | S |
D349018 | Kaiser | Jul 1994 | S |
D351472 | Mason et al. | Oct 1994 | S |
D352633 | Berggren | Nov 1994 | S |
D353892 | Shaw et al. | Dec 1994 | S |
5375278 | Vanwinkle et al. | Dec 1994 | A |
D354138 | Kelly | Jan 1995 | S |
D355457 | Miller | Feb 1995 | S |
D356329 | Frillot | Mar 1995 | S |
D357747 | Kelly | Apr 1995 | S |
5409500 | Dyrek | Apr 1995 | A |
D360920 | Lessard | Aug 1995 | S |
D363670 | Sullivan | Oct 1995 | S |
D369218 | Vandenbelt | Apr 1996 | S |
5545197 | Bowen | Aug 1996 | A |
5628772 | Russell | May 1997 | A |
D383213 | Ingram | Sep 1997 | S |
D383546 | Amis et al. | Sep 1997 | S |
D383547 | Mason et al. | Sep 1997 | S |
D383848 | Mason et al. | Sep 1997 | S |
D384703 | Chuang | Oct 1997 | S |
D387506 | Kosh | Dec 1997 | S |
5707645 | Wierson | Jan 1998 | A |
D390057 | Gower | Feb 1998 | S |
D392742 | Clark, Sr. | Mar 1998 | S |
D392787 | Barratt | Mar 1998 | S |
5800491 | Kolen et al. | Sep 1998 | A |
D401317 | Gillies | Nov 1998 | S |
D402147 | Scarborough | Dec 1998 | S |
5842475 | Duback et al. | Dec 1998 | A |
D403774 | Laughlin et al. | Jan 1999 | S |
D406350 | Cutler | Mar 1999 | S |
D407823 | Davis et al. | Apr 1999 | S |
D407939 | Bear | Apr 1999 | S |
5895656 | Hirschowitz et al. | Apr 1999 | A |
5897580 | Silver | Apr 1999 | A |
D410090 | Podd | May 1999 | S |
D410165 | Bear | May 1999 | S |
D410167 | Bear | May 1999 | S |
D410749 | Podd | Jun 1999 | S |
D410750 | Podd | Jun 1999 | S |
D411624 | Podd | Jun 1999 | S |
5925072 | Cramer et al. | Jul 1999 | A |
5978962 | Hamowy | Nov 1999 | A |
5984953 | Sabin et al. | Nov 1999 | A |
D420178 | Blonde et al. | Feb 2000 | S |
D426308 | Negron | Jun 2000 | S |
6080121 | Madow et al. | Jun 2000 | A |
6083254 | Evans | Jul 2000 | A |
D429818 | Lamping et al. | Aug 2000 | S |
6099555 | Sabin | Aug 2000 | A |
D431269 | Soderstrom | Sep 2000 | S |
D433757 | Jordan | Nov 2000 | S |
D434506 | Jordan | Nov 2000 | S |
6146413 | Harman | Nov 2000 | A |
6152892 | Masini | Nov 2000 | A |
D436019 | Thomas | Jan 2001 | S |
D436179 | Small | Jan 2001 | S |
D436525 | Lin | Jan 2001 | S |
D438307 | Scheppke | Feb 2001 | S |
D442078 | Fuquen | May 2001 | S |
D442278 | Rury | May 2001 | S |
D442285 | Perry | May 2001 | S |
6226820 | Navarro | May 2001 | B1 |
6241711 | Weissberg et al. | Jun 2001 | B1 |
D446927 | Rotschild | Aug 2001 | S |
D448850 | Fabricant | Oct 2001 | S |
6320094 | Arnold et al. | Nov 2001 | B1 |
D453223 | Sherman | Jan 2002 | S |
6336220 | Sacks et al. | Jan 2002 | B1 |
D453541 | Steele et al. | Feb 2002 | S |
6361553 | Bowen | Mar 2002 | B1 |
D459986 | Yourist | Jul 2002 | S |
D460914 | Yourist | Jul 2002 | S |
6420623 | Augustine et al. | Jul 2002 | B2 |
D461903 | Garcia | Aug 2002 | S |
D466610 | Ashton et al. | Dec 2002 | S |
6524331 | Kohout et al. | Feb 2003 | B1 |
D473940 | Hantke et al. | Apr 2003 | S |
D473947 | Jacobsen | Apr 2003 | S |
D476080 | Hantke et al. | Jun 2003 | S |
D477086 | Tsuruda et al. | Jul 2003 | S |
6610084 | Torres | Aug 2003 | B1 |
6648909 | Helming | Nov 2003 | B2 |
D484240 | Lyons et al. | Dec 2003 | S |
D484985 | Takizawa et al. | Jan 2004 | S |
D486603 | Larkin et al. | Feb 2004 | S |
6755852 | Lachenbruch et al. | Jun 2004 | B2 |
D505041 | Lesosky | May 2005 | S |
D507056 | Friedland | Jul 2005 | S |
6916334 | Noonan | Jul 2005 | B2 |
D512511 | Friedland | Dec 2005 | S |
6972029 | Mayrhofer et al. | Dec 2005 | B2 |
7022130 | Gammons et al. | Apr 2006 | B2 |
D525533 | Edwards | Jul 2006 | S |
D527108 | Krahner | Aug 2006 | S |
D531790 | Wurzburg | Nov 2006 | S |
D532523 | Krahner et al. | Nov 2006 | S |
D533668 | Brown | Dec 2006 | S |
D537161 | Sinkiewicz | Feb 2007 | S |
7182777 | Mills | Feb 2007 | B2 |
D538974 | Eknoian et al. | Mar 2007 | S |
7195660 | Little et al. | Mar 2007 | B2 |
7220889 | Sigurjonsson et al. | May 2007 | B2 |
D545441 | Miyachika et al. | Jun 2007 | S |
D548405 | Purnell | Aug 2007 | S |
D550852 | Hoffman et al. | Sep 2007 | S |
7291164 | Peterman et al. | Nov 2007 | B2 |
D557810 | Eknoian et al. | Dec 2007 | S |
D564705 | Ohnishi et al. | Mar 2008 | S |
D565740 | Sybrandts | Apr 2008 | S |
D569035 | Eknoian et al. | May 2008 | S |
D570488 | Kirksey et al. | Jun 2008 | S |
D570541 | Ohnishi et al. | Jun 2008 | S |
7393336 | Sloot | Jul 2008 | B2 |
D574962 | Atkins et al. | Aug 2008 | S |
D574999 | Eknoian et al. | Aug 2008 | S |
D575875 | Robinson et al. | Aug 2008 | S |
D576282 | Yanaki | Sep 2008 | S |
D577606 | Friedland et al. | Sep 2008 | S |
D588703 | Boleratz | Mar 2009 | S |
D592001 | Smith | May 2009 | S |
D596305 | Usui et al. | Jul 2009 | S |
D597678 | Wagner | Aug 2009 | S |
D605299 | Iwahashi et al. | Dec 2009 | S |
D608500 | Lu et al. | Jan 2010 | S |
7652228 | Igaki et al. | Jan 2010 | B2 |
D613181 | Friedland et al. | Apr 2010 | S |
D615278 | Reed | May 2010 | S |
7707655 | Braunecker et al. | May 2010 | B2 |
D616760 | Deuerer | Jun 2010 | S |
D618357 | Navies | Jun 2010 | S |
D618811 | Navies | Jun 2010 | S |
D620123 | Igwebuike | Jul 2010 | S |
D622449 | Culley et al. | Aug 2010 | S |
D624346 | Salzman | Sep 2010 | S |
D626243 | Sagnip et al. | Oct 2010 | S |
D627527 | Ferguson et al. | Nov 2010 | S |
D627586 | Holdrige | Nov 2010 | S |
D629589 | Mayo | Dec 2010 | S |
7854712 | Evans et al. | Dec 2010 | B2 |
D630376 | Yamamoto | Jan 2011 | S |
D634473 | Koike | Mar 2011 | S |
D635272 | Gruber et al. | Mar 2011 | S |
7937909 | Carvallo | May 2011 | B2 |
D646842 | Roman | Oct 2011 | S |
D647146 | Islava | Oct 2011 | S |
D648439 | Greener et al. | Nov 2011 | S |
D649647 | Williams | Nov 2011 | S |
D651719 | Kusmierz | Jan 2012 | S |
D656235 | Howell | Mar 2012 | S |
D660447 | Baltazar | May 2012 | S |
8226699 | Evans | Jul 2012 | B2 |
D667957 | Baumwald | Sep 2012 | S |
D668343 | Baumwald et al. | Oct 2012 | S |
D668344 | Baumwald et al. | Oct 2012 | S |
D668345 | Baumwald et al. | Oct 2012 | S |
8281450 | Spain | Oct 2012 | B2 |
D670816 | Suzuki et al. | Nov 2012 | S |
D671225 | Higley | Nov 2012 | S |
D674903 | Harder | Jan 2013 | S |
D676469 | Vanettes et al. | Feb 2013 | S |
D677394 | Grust et al. | Mar 2013 | S |
8581017 | Holm et al. | Nov 2013 | B2 |
D818596 | Zheng | May 2018 | S |
D821597 | Martinez | Jun 2018 | S |
D822219 | Coates | Jul 2018 | S |
20030064042 | Bergquist et al. | Apr 2003 | A1 |
20040010302 | Van Hoffman et al. | Jan 2004 | A1 |
20040138601 | Chalmers | Jul 2004 | A1 |
20040147991 | Lu | Jul 2004 | A1 |
20050187598 | Shimizu et al. | Aug 2005 | A1 |
20060015052 | Crisp | Jan 2006 | A1 |
20070021810 | Paulin | Jan 2007 | A1 |
20070068508 | York-Leung Wong | Mar 2007 | A1 |
20070252115 | Arehart | Nov 2007 | A1 |
20070262290 | Beck et al. | Nov 2007 | A1 |
20080039763 | Sigurjonsson et al. | Feb 2008 | A1 |
20080119916 | Choucair et al. | May 2008 | A1 |
20080208299 | Martineau | Aug 2008 | A1 |
20090048650 | Junkins | Feb 2009 | A1 |
20090143516 | MacDonald | Jun 2009 | A1 |
20090163984 | Robinson et al. | Jun 2009 | A1 |
20100010597 | Evans | Jan 2010 | A1 |
20100217363 | Whitely | Aug 2010 | A1 |
20120165910 | Choucair et al. | Jun 2012 | A1 |
20130073018 | Harwood | Mar 2013 | A1 |
20140291585 | Tozuka | Oct 2014 | A1 |
20140316314 | Schubert | Oct 2014 | A1 |
Number | Date | Country |
---|---|---|
103788939 | May 2014 | CN |
105400359 | Mar 2016 | CN |
106750466 | May 2017 | CN |
107325220 | Nov 2017 | CN |
107550627 | Jan 2018 | CN |
107647962 | Feb 2018 | CN |
108440883 | Aug 2018 | CN |
0162583 | Nov 1985 | EP |
2006045408 | Feb 2006 | JP |
2006045464 | Feb 2006 | JP |
20170024708 | Mar 2017 | KR |
2001078797 | Oct 2001 | WO |
2016093788 | Jun 2016 | WO |
Entry |
---|
Translation of Kitsunai '408 provided by Espacenet. |
Translation of Kitsunai '464 provided by Espacenet. |
PCT/US17/38880, Jun. 23, 2017, ISA, Written Opinion of the International Search Authority, dated Nov. 17, 2017. |
Palcare Catalog: 2008 Presentations (attached). |
Kendall Obstetric & Neonatal Products Brochure, Jan. 2004 ed. (attached). |
http://www.itamed.com/our-products/maternity-womens-s-health-collection/post-surgical.html?, printed Mar. 18, 2016 (attached). |
Entire prosecution history of U.S. Appl. No. 29/433,566. |
Entire prosecution history of U.S. Appl. No. 29/406,624. |
Entire prosecution history of U.S. Appl. No. 29/406,623. |
Entire prosecution history of U.S. Appl. No. 29/406,622. |
Entire prosecution history of U.S. Appl. No. 29/403,478. |
Entire prosecution history of U.S. Appl. No. 29/402,971. |
Entire prosecution history of U.S. Appl. No. 29/402,951. |
Entire prosecution history of U.S. Appl. No. 29/402,974. |
Entire prosecution history of U.S. Appl. No. 29/403,056. |
Entire prosecution history of U.S. Appl. No. 10/672,132. |
Entire prosecution history of U.S. Appl. No. 29/435,901. |
Entire prosecution history of U.S. Appl. No. 29/435,900. |
Entire prosecution history of U.S. Appl. No. 29/435,896. |
Entire prosecution history of U.S. Appl. No. 29/644,303. |
Entire prosecution history of U.S. Appl. No. 29/558,760. |
Entire prosecution history of U.S. Appl. No. 29/498,786. |
Entire prosecution history of U.S. Appl. No. 29/429,157. |
Entire prosecution history of U.S. Appl. No. 29/644,302. |
Entire prosecution history of U.S. Appl. No. 29/558,755. |
Entire prosecution history of U.S. Appl. No. 29/498,785. |
Entire prosecution history of U.S. Appl. No. 29/429,154. |
Entire prosecution history of U.S. Appl. No. 29/644,299. |
Entire prosecution history of U.S. Appl. No. 29/498,781. |
Entire prosecution history of U.S. Appl. No. 29/429,147. |
Entire prosecution history of U.S. Appl. No. 29/647,787. |
Entire prosecution history of U.S. Appl. No. 29/558,747. |
Entire prosecution history of U.S. Appl. No. 29/498,780. |
Entire prosecution history of U.S. Appl. No. 29/429,143. |
Entire prosecution history of U.S. Appl. No. 12/794,576. |
Entire prosecution history of U.S. Appl. No. 29/499,977. |
Entire prosecution history of U.S. Appl. No. 29/434,763. |
Entire prosecution history of U.S. Appl. No. 29/431,399. |
Entire prosecution history of U.S. Appl. No. 29/433,806. |
Entire prosecution history of U.S. Appl. No. 29/433,805. |
Entire prosecution history of U.S. Appl. No. 29/433,907. |
Entire prosecution history of U.S. Appl. No. 29/435,893. |
Entire prosecution history of U.S. Appl. No. 29/434,760. |
Entire prosecution history of U.S. Appl. No. 29/434,757. |
Entire prosecution history of U.S. Appl. No. 29/413,705. |
Entire prosecution history of U.S. Appl. No. 29/433,570. |
Entire prosecution history of U.S. Appl. No. 29/433,568. |
Entire prosecution history of U.S. Appl. No. 29/433,567. |
Entire prosecution history of U.S. Appl. No. 29/410,930. |
Entire prosecution history of U.S. Appl. No. 29/480,356. |
Entire prosecution history of U.S. Appl. No. 29/431,148. |
Entire prosecution history of U.S. Appl. No. 29/410,928. |
Entire prosecution history of U.S. Appl. No. 29/558,750. |
Int'l Search Report & Written Opinion, PCT/CN2018/077916 (ISA-CN dated Dec. 3, 2018). |
Number | Date | Country | |
---|---|---|---|
20190269548 A1 | Sep 2019 | US |